Does dietary knowledge for functional insulin therapy affect eating disorder risk in adults with type 1 diabetes?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, monocentric observational study run from Grenoble with national recruitment that collects data remotely to limit participant burden. Participants complete an online questionnaire, a videoconference session to measure FIT-related dietary knowledge and screen for eating disorder risk, then a self-administered follow-up questionnaire and a final videoconference interview. Adults with confirmed type 1 diabetes diagnosed at least three months prior who can use a smartphone or computer are eligible, while those unable to complete online visits, pregnant or under legal guardianship are excluded. The primary aim is to determine whether higher levels of FIT dietary knowledge are associated with an increased risk of disordered eating behaviors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of type 1 diabetes confirmed by a referring physician
* Diagnosis received at least three months prior
* Adult (18 years or older)
* Access to a computer or smartphone capable of videoconferencing
* No expressed opposition to participation
* Consent for image rights (for Phase 2 qualitative interviews)

Exclusion Criteria:

* Inability to complete online questionnaires and participate in a 45-minute videoconference interview
* Being under legal guardianship or curatorship
* Being pregnant or breastfeeding

Where it's running

• Grenoble
  Grenoble, France Recruiting

Study contacts

• Study coordinator: Cécile BERTY
• Email: CBetry@chu-grenoble.fr
• Phone: 0476765509

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Benefits of Retained Insulin for Good Health in Diabetes

  This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

  Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

• Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic

  This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.

  Recruiting at 3 sites Life for a Child Program, Diabetes Australia · Santiago de los Caballeros and 2 other locations · NCT07742306

• AI-assisted remote insulin pump optimization for people with type 1 diabetes

  This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.

  Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07732777

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

• Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work

  We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.

  Recruiting Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · Málaga, Málaga · NCT07667504

• Islet re-transplantation after prior graft failure in adults with type 1 diabetes

  This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07666789

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.